Table 5 Response rate by proportion of papillary and sarcomatoid features

From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

	None	<10 %	10–30 %	>30 %
Papillary	N = 105	N = 27	N = 3	N = 8
ORR	43 (40.9)	14 (51.9)	2 (66.7)	1 (12.5)
CRR	20 (19.0)	6 (22.2)	2 (66.7)	0
Sarcomatoid	N = 125	N = 12	N = 6	N = 2
ORR	56 (44.8)	6 (50.0)	0	0
CR	28 (22.4)	2 (16.7)	0	0

Back to article page